4.7 Article

Reduced Reward Learning Predicts Outcome in Major Depressive Disorder

期刊

BIOLOGICAL PSYCHIATRY
卷 73, 期 7, 页码 639-645

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2012.10.014

关键词

Anhedonia; major depression; psychopathology; outcome; reward learning task; reward responsiveness

资金

  1. Johnson Johnson
  2. University of Leuven [OT06/60]
  3. Fund for Scientific Research, Flanders, Belgium (Fonds voor wetenschappelijk onderzoek) [ELG-B5588-G.0193.07]
  4. Servier
  5. Lundbeck
  6. Eli Lilly
  7. AstraZeneca
  8. National Institute of Mental Health [R01MH68376, R21MH078979]
  9. Shire
  10. Ono Pharma USA

向作者/读者索取更多资源

Background: Reduced reward learning might contribute to the onset and maintenance of major depressive disorder (MDD). In particular, the inability to utilize rewards to guide behavior is hypothesized to be associated with anhedonia, a core feature and potential trait marker of MDD. Few studies have investigated whether reduced reward learning normalizes with treatment and/or reward learning predicts clinical outcome. Our goal was to test whether MDD is characterized by reduced reward learning, especially in the presence of anhedonic symptoms, and to investigate the relationship between reward learning and MDD diagnosis after 8 weeks of treatment. Methods: Seventy-nine inpatients and 63 healthy control subjects performed a probabilistic reward task yielding an objective measure of participants' ability to modulate behavior as a function of reward. We compared reward responsiveness between depressed patients and control subjects, as well as high- versus low-anhedonic MDD patients. We also evaluated whether reward-learning deficits predicted persistence of MDD after 8 weeks of treatment. Results: Relative to control subjects, MDD patients showed reduced reward learning. Moreover, patients with high anhedonia showed diminished reward learning compared with patients with low anhedonia. Reduced reward learning at study entry increased the odds of a persisting diagnosis of MDD after 8 weeks of treatment (odds ratio 7.84). Conclusions: Our findings indicate that depressed patients, especially those with anhedonic features, are characterized by an impaired ability to modulate behavior as a function of reward. Moreover, reduced reward learning increased the odds for the diagnosis of MDD to persist after 8 weeks of treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据